Ocular Therapeutix Cuts 37 Positions to Focus on Axpaxli Implant Development
In a recent development, Ocular Therapeutix's board has approved a strategic layoff affecting 37 full-time employees, representing 13% of...
Revolutionize Your Finance News Experience with MorningExpert!
🌟 Custom-Tailored News Just for You: Say goodbye to information overload. Our cutting-edge filtering technology curates your feed to perfection, delivering only the finance news that matches your interests and professional ambitions.
🔔 Flexible Updates, Your Way: How do you like your updates? Choose from instant app notifications, email digests, or captivating video summaries to stay informed on your own terms.
🎥 Engaging Video Summaries: Pressed for time? Let our expert anchors brief you with video summaries, giving you the essence of each news piece in minutes.
🚨 Personalized Alerts: Never miss out on what matters most. Set custom alarms for topics you’re passionate about, and be the first in the know.
📹 Create Your Own Video Content: Dive deeper into the topics that intrigue you with personalized videos. Generated on demand, these videos bring your chosen keywords or interests to life.
MorningExpert is more than a news app; it’s a dedicated companion for anyone passionate about finance. Whether you’re a seasoned professional, an avid enthusiast, or simply eager to stay updated with the finance world, our app ensures you’re always ahead of the curve.
With features designed to make staying informed effortless and enjoyable—such as custom alarms and on-demand video content—navigating the finance landscape has never been simpler or more tailored to your needs.
Transform the way you consume finance news. Download MorningExpert now and step into a world of precision-informed finance knowledge. Your next-level finance journey starts here!
acquisition adjusted earnings AI analysts apple artificial intelligence Bitcoin CEO China demand dividend Donald Trump Dow Jones Industrial Average earnings economy extreme event FactSet Federal Reserve fourth quarter growth guidance hamas inflation interest rates investment investors Israel Microsoft net income net profit Nvidia profit revenue revenue growth S&P 500 sales shareholders shares stock stock market stocks tesla third quarter Trump Wall Street
In a recent development, Ocular Therapeutix's board has approved a strategic layoff affecting 37 full-time employees, representing 13% of...
Lead: EyePoint Pharmaceuticals Inc. shares plummeted nearly 30% after its diabetic eye disease treatment failed in a clinical trial,...
Shares of 4D Molecular Therapeutics surged 33% to $23.20 in premarket trading following positive interim data from a Phase...
Shares of 4D Molecular Therapeutics surged 76% to $30.83 after the company announced positive interim data from a Phase...
Shares of biopharmaceutical company Outlook Therapeutics soared in premarket trading after the company announced two significant developments in its...
Shares of 4D Molecular Therapeutics surged after the FDA granted regenerative medicine advanced therapy designation to its treatment for...
EyePoint Pharmaceutics Inc.'s stock has skyrocketed 362% after the company announced positive results from a Phase 2 trial of...
The European Medicines Agency's Committee for Medicinal Products for Human Use has recommended the approval of a high-dose formulation...
Outlook Therapeutics shares plummeted over 50% in premarket trading after the biopharmaceutical company announced the need for another study...